{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:44:55Z","timestamp":1792730695321,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Blastocystis spp.<\/jats:italic>\n                      (BC) often passes as a harmless resident of the gut. However, it may be associated with gastrointestinal disturbances, such as abdominal pain and diarrhea. The variation in the clinical spectrum of BC infection is, in part, due to its diverse genotypic profile, where ongoing research continues to discover new BC subtypes. This study aimed at investigating the association between different BC subtypes and intestinal inflammation as assessed by fecal calprotectin (FCP) and tumor necrosis factor alpha (TNF-\u03b1) levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients complaining of gastrointestinal tract (GIT) symptoms were investigated for the presence of BC infection by microscopy and stool culture on Jones\u2019 medium. Out of 163 patients, 88 were confirmed to be infected with BC. They were further divided according to the dominant BC subtype by RFLP genotyping. Patients were treated with metronidazole at a dose of 250\u00a0mg 3 times daily for ten days and were evaluated for symptom improvement after the treatment course. Moreover, FCP and TNF-\u03b1 levels were measured in stool samples by ELISA before and after therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>BC subtype 3 was found to be the dominant subtype in 62 samples (70.5%), while subtype 4 was dominant in 26 samples (29.5%). A higher number of patients infected with BC subtype 3 reported the presence of GIT manifestations. After treatment, 17 subtype 3-infected patients (27.4%) witnessed improvement of their GIT symptoms, as compared to 9 patients infected with BC subtype 4 (34.6%). In subtype 3 infected patients, 71% were free of BC stages by both microscopic examination and stool culture, while 92.3% of patients infected with subtype 4 showed fecal parasite clearance. FCP and TNF-\u03b1 levels were higher in patients infected with BC subtype 3 as compared to BC subtype 4, both before and after treatment with metronidazole. In the BC subtype 3-infected groups, fecal TNF-\u03b1 and FCP levels decreased significantly after treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In our cohort study, BC subtype 3 was the most prevalent subtype among patients reporting gastrointestinal symptoms. The ST3 group exhibited numerically higher inflammatory markers compared to ST4. These trends shed light on the potential link between\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      genetic diversity and intestinal inflammation. Although the observational nature of this study and the unequal group sizes limit the ability to establish a definitive causal relationship, these findings provide a BC subtype-oriented diagnostic and therapeutic design within a hospital-based setting that could facilitate the design of more tailored management strategies for patients with BC-associated symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13047-6","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:06:50Z","timestamp":1775117210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of Blastocystis species subtypes 3 and 4 with intestinal inflammation and response to metronidazole in symptomatic patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Noha M.","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira R.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa M.","family":"Abdel Aal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly","family":"ELkazaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohamed","family":"Shenawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa Mohamed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa","family":"Saad El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda SA","family":"Abdeltawab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"13047_CR1","doi-asserted-by":"publisher","first-page":"15840","DOI":"10.1038\/s41598-022-18308-3","volume":"12","author":"J Chaparro-Olaya","year":"2022","unstructured":"Chaparro-Olaya J, Morales L, Le\u00f3n Falla MD, et al. Decreased fecal calprotectin levels in Spondyloarthritis patients colonized by Blastocystis spp. Sci Rep. 2022;12:15840. https:\/\/doi.org\/10.1038\/s41598-022-18308-3.","journal-title":"Sci Rep"},{"issue":"1","key":"13047_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1757-4749-6-17","volume":"6","author":"T Roberts","year":"2014","unstructured":"Roberts T, Stark D, Harkness J, Ellis J. Update on the pathogenic potential and treatment options for Blastocystis sp. Gut Pathogens. 2014;6(1):17.","journal-title":"Gut Pathogens"},{"key":"13047_CR3","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s00436-017-5535-6","volume":"116","author":"A Rostami","year":"2017","unstructured":"Rostami A, Riahi SM, Haghighi A, Saber V, Armon B, Seyyedtabaei SJ. The role of blastocystis sp. and dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis. Parasitol Res. 2017;116:2361\u201371.","journal-title":"Parasitol Res"},{"issue":"1","key":"13047_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/2229-5070.113901","volume":"3","author":"U Sekar","year":"2013","unstructured":"Sekar U, Shanthi M, Blastocystis. Consensus of treatment and controversies. Trop Parasitol. 2013;3(1):35\u20139. https:\/\/doi.org\/10.4103\/2229-5070.113901. PMID: 23961439; PMCID: PMC3745668.","journal-title":"Trop Parasitol"},{"issue":"6","key":"13047_CR5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/microorganisms12061084","volume":"12","author":"C Matovelle","year":"2024","unstructured":"Matovelle C, Qu\u00edlez J, Tejedor MT, Beltr\u00e1n A, Chueca P, Monteagudo LV. Subtype Distribution of Blastocystis spp. in patients with gastrointestinal symptoms in Northern Spain. Microorganisms. 2024;12(6):1084. https:\/\/doi.org\/10.3390\/microorganisms12061084.","journal-title":"Microorganisms"},{"key":"13047_CR6","doi-asserted-by":"publisher","first-page":"967724","DOI":"10.3389\/fcimb.2022.967724","volume":"12","author":"L Rojas-Vel\u00e1zquez","year":"2022","unstructured":"Rojas-Vel\u00e1zquez L, Mor\u00e1n P, Serrano-V\u00e1zquez A, Portillo-Bobadilla T, Gonz\u00e1lez E, P\u00e9rez-Ju\u00e1rez H, Hern\u00e1ndez E, Partida-Rodr\u00edguez O, Nieves-Ram\u00edrez M, Padilla A, Zaragoza M, Xim\u00e9nez C. The regulatory function of Blastocystis spp. on the immune inflammatory response in the gut microbiome. Front Cell Infect Microbiol. 2022;12:967724. https:\/\/doi.org\/10.3389\/fcimb.2022.967724.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"13047_CR7","doi-asserted-by":"publisher","first-page":"e1009253","DOI":"10.1371\/journal.ppat.1009253","volume":"17","author":"L Deng","year":"2021","unstructured":"Deng L, Wojciech L, Gascoigne NRJ, Peng G, Tan KSW. New insights into the interactions between Blastocystis, the gut microbiota, and host immunity. PLoS Pathog. 2021;17(2):e1009253. https:\/\/doi.org\/10.1371\/journal.ppat.1009253.","journal-title":"PLoS Pathog"},{"issue":"9","key":"13047_CR8","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/microorganisms12091924","volume":"12","author":"S Tocci","year":"2024","unstructured":"Tocci S, Das S, Sayed IM. An update on Blastocystis: possible mechanisms of Blastocystis-mediated colorectal cancer. Microorganisms. 2024;12(9):1924. https:\/\/doi.org\/10.3390\/microorganisms12091924.","journal-title":"Microorganisms"},{"issue":"18","key":"13047_CR9","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.3748\/wjg.v29.i18.2733","volume":"29","author":"RF Souza","year":"2023","unstructured":"Souza RF, Caetano MAF, Magalh\u00e3es HIR, Castelucci P. Study of tumor necrosis factor receptor in the inflammatory bowel disease. World J Gastroenterol. 2023;29(18):2733\u201346. https:\/\/doi.org\/10.3748\/wjg.v29.i18.2733. PMID: 37274062; PMCID: PMC10237104.","journal-title":"World J Gastroenterol"},{"key":"13047_CR10","doi-asserted-by":"publisher","first-page":"940332","DOI":"10.3389\/fmed.2022.940332","volume":"9","author":"M Norouzi","year":"2022","unstructured":"Norouzi M, Pirestani M, Arefian E, Dalimi A, Sadraei J, Mirjalali H. Exosomes secreted by Blastocystis subtypes affect the expression of proinflammatory and anti-inflammatory cytokines (TNF\u03b1, IL-6, IL-10, IL-4). Front Med (Lausanne). 2022;9:940332. PMID: 36035429; PMCID: PMC9404381.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"13047_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","volume":"10","author":"RC Russo","year":"2014","unstructured":"Russo RC, Garcia CC, Teixeira MM, Amaral FA. The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(5):593\u2013619. https:\/\/doi.org\/10.1586\/1744666X.2014.894886. Epub 2014\/04\/01.","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"13047_CR12","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.3390\/diagnostics12102554","volume":"12","author":"G Cardiero","year":"2022","unstructured":"Cardiero G, Palma D, Vano M, Anastasio C, Pinchera B, Ferrandino M, Gianfico C, Gentile L, Savoia M, Gentile I, Di Taranto MD, Fortunato G. Calprotectin levels and neutrophil count are prognostic markers of mortality in COVID-19 patients. Diagnostics (Basel). 2022;12(10):2554. https:\/\/doi.org\/10.3390\/diagnostics12102554.","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"13047_CR13","first-page":"77","volume":"39","author":"WGW Pathirana","year":"2018","unstructured":"Pathirana WGW, Chubb SP, Gillett MJ, Vasikaran SD. Faecal Calprotectin. Clin Biochemist Reviews. 2018;39(3):77\u201390. PMID: 30828114; PMCID: PMC6370282.","journal-title":"Clin Biochemist Reviews"},{"issue":"3","key":"13047_CR14","first-page":"183","volume":"12","author":"T Azramezani Kopi","year":"2019","unstructured":"Azramezani Kopi T, Shahrokh SH, Mirzaei A, Asadzadeh Aghdaei H, Amini Kadijani A. The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study. Gastroenterol Hepatol Bed Bench. 2019;12(3):183\u201389.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"8","key":"13047_CR15","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/healthcare9080956","volume":"9","author":"M Giuffr\u00e8","year":"2021","unstructured":"Giuffr\u00e8 M, Vetrugno L, Di Bella S, Moretti R, Berretti D, Croc\u00e8 LS. Calprotectin and SARS-CoV-2: a brief-report of the current literature. Healthc (Basel). 2021;9(8):956. https:\/\/doi.org\/10.3390\/healthcare9080956.","journal-title":"Healthc (Basel)"},{"issue":"2","key":"13047_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5114\/pg.2023.129412","volume":"18","author":"E Szymanska","year":"2023","unstructured":"Szymanska E, Szymanska S, Dadalski M, Kierkus J. Biological markers of disease activity in inflammatory bowel diseases. Gastroenterol Review\/Przegl\u0105d Gastroenterologiczny. 2023;18(2):141\u20137. https:\/\/doi.org\/10.5114\/pg.2023.129412.","journal-title":"Gastroenterol Review\/Przegl\u0105d Gastroenterologiczny"},{"issue":"6","key":"13047_CR17","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.20546\/ijcmas.2017.606.384","volume":"6","author":"YJ Salman","year":"2016","unstructured":"Salman YJ, Ali CA, Abdul Razaq AA. Fecal calprotectin among patients infected with some protozoan infections. Int J Curr Microbiol Appl Sci. 2016;6(6):3258\u201374. https:\/\/doi.org\/10.20546\/ijcmas.2017.606.384.","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"13047_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1051\/parasite\/2023065","volume":"30","author":"M Boutahar","year":"2023","unstructured":"Boutahar M, Belaouni M, Ibrahimi A, Eljaoudi R, Aanniz T, Er-Rami M. Prevalence of Blastocystis sp. in Morocco: Comparative assessment of three diagnostic methods and characterization of parasite forms in Jones\u2019 culture medium. Parasite. 2023;30:64. https:\/\/doi.org\/10.1051\/parasite\/2023065.","journal-title":"Parasite"},{"key":"13047_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13027-017-0131-z","volume":"12","author":"AM Mohamed","year":"2017","unstructured":"Mohamed AM, Ahmed MA, Ahmed SA, Al-Semany SA, Alghamdi SS, Zaglool DA. Predominance and association risk of Blastocystis hominis subtype I in colorectal cancer: a case control study. Infect Agent Cancer. 2017;12:21. https:\/\/doi.org\/10.1186\/s13027-017-0131-z.","journal-title":"Infect Agent Cancer"},{"issue":"4","key":"13047_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00436-005-1363-1","volume":"96","author":"DD Moghaddam","year":"2005","unstructured":"Moghaddam DD, Ghadirian E, Azami M. Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim\/sulfamethoxazole. Parasitol Res. 2005;96(4):273\u20135. https:\/\/doi.org\/10.1007\/s00436-005-1363-1. Epub 2005 May 25. PMID: 15915364.","journal-title":"Parasitol Res"},{"issue":"3","key":"13047_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.21608\/Jesp.2021.210455","volume":"51","author":"A Raafat","year":"2021","unstructured":"Raafat A, Abdel-Shafi IR, Ismail M, Amin N. Efficacy of fecal calprotectin as a marker for the pathogenicity of blastocystis hominis. J Egypt Soc Parasitol. 2021;51(3):641\u20136. https:\/\/doi.org\/10.21608\/Jesp.2021.210455.","journal-title":"J Egypt Soc Parasitol"},{"issue":"1","key":"13047_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.21608\/puj.2021.51301.1095","volume":"14","author":"N Amin","year":"2021","unstructured":"Amin N, Raafat A, Morsy S. Detection rate and genotyping of Cryptosporidium spp. and its relation to copro TNF-\u03b1 in elderly Egyptians attending outpatient clinics of Cairo University Hospitals. Parasitologists United J. 2021;14(1):77\u201385. https:\/\/doi.org\/10.21608\/puj.2021.51301.1095.","journal-title":"Parasitologists United J"},{"issue":"1","key":"13047_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jiph.2017.03.009","volume":"11","author":"S Khademvatan","year":"2018","unstructured":"Khademvatan S, Masjedizadeh R, YousefiRazin E, Mahbodfar H, Rahim F, et al. PCR-based molecular characterization of Blastocystis sp. subtypes in southwest of Iran. J Infect Public Health. 2018;11(1):43\u20137.","journal-title":"J Infect Public Health"},{"key":"13047_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2147\/IDR.S347220","volume":"15","author":"MH Wakid","year":"2022","unstructured":"Wakid MH, Aldahhasi WT, Alsulami MN, El-Kady AM, Elshabrawy HA. Identification and Genetic Characterization of Blastocystis Species in Patients from Makkah, Saudi Arabia. Infect Drug Resist. 2022;15:491\u2013501. https:\/\/doi.org\/10.2147\/IDR.S347220.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"13047_CR25","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s12639-021-01354-5","volume":"45","author":"SM Abdo","year":"2021","unstructured":"Abdo SM, El-Adawy H, Farag HF, El-Taweel HA, Elhadad H, El-Badry AA. Detection and molecular identification of Blastocystis isolates from humans and cattle in northern Egypt. J Parasitic Dis. 2021;45(3):738\u201345. https:\/\/doi.org\/10.1007\/s12639-021-01354-5.","journal-title":"J Parasitic Dis"},{"key":"13047_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00436-017-5679-4","volume":"117","author":"AA El-Badry","year":"2018","unstructured":"El-Badry AA, Abd El Wahab WM, Hamdy DA, et al. Blastocystis subtypes isolated from irritable bowel syndrome patients and co-infection with Helicobacter pylori. Parasitol Res. 2018;117:127\u201337. https:\/\/doi.org\/10.1007\/s00436-017-5679-4.","journal-title":"Parasitol Res"},{"key":"13047_CR27","doi-asserted-by":"publisher","first-page":"19084","DOI":"10.1038\/s41598-022-23360-0","volume":"12","author":"SA Ahmed","year":"2022","unstructured":"Ahmed SA, El-Mahallawy HS, Mohamed SF, et al. Subtypes and phylogenetic analysis of Blastocystis sp. isolates from West Ismailia. Egypt Sci Rep. 2022;12:19084. https:\/\/doi.org\/10.1038\/s41598-022-23360-0.","journal-title":"Egypt Sci Rep"},{"issue":"4","key":"13047_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11686-025-01079-y","volume":"70","author":"A Shehab","year":"2025","unstructured":"Shehab A, El-Sayad M, Allam A, Mohamed B, Elsaka R, Ibrahim M, El-Latif NA. Insights into the Association Between Blastocystis infection and colorectal cancer. Acta Parasitol. 2025;70(4):156. https:\/\/doi.org\/10.1007\/s11686-025-01079-y. PMID: 40658265; PMCID: PMC12259763.","journal-title":"Acta Parasitol"},{"issue":"1","key":"13047_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12879-024-10423-y","volume":"25","author":"G Salehi Sangani","year":"2025","unstructured":"Salehi Sangani G, Hosseini-Safa A, Hosseini Farash BR, Salehi Sangani P, Zarean M, Moghaddas E, Zoghdar Moghadam S, Jarahi L, Gholizadeh A, Berenji F. Detection and subtyping of Blastocystis sp. in human and animal stool samples using high-resolution melting analysis. BMC Infect Dis. 2025;25(1):171. https:\/\/doi.org\/10.1186\/s12879-024-10423-y. PMID: 39910463; PMCID: PMC11800531.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13047_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/pathogens8010038","volume":"8","author":"N Srichaipon","year":"2019","unstructured":"Srichaipon N, Nuchprayoon S, Charuchaibovorn S, Sukkapan P, Sanprasert V. A simple genotyping method for rapid differentiation of Blastocystis subtypes and subtype distribution of Blastocystis spp. Thail Pathogens. 2019;8(1):38. https:\/\/doi.org\/10.3390\/pathogens8010038. PMID: 30901902; PMCID: PMC6471993.","journal-title":"Thail Pathogens"},{"key":"13047_CR31","unstructured":"Sankur F, Ayturan S, Malatyali E, Ertabaklar H, Ertug S. The distribution of Blastocystis subtypes among school-aged children in Mugla, Turkey. Iran J Parasitol. 2017 Oct-Dec;12(4):580\u20136. PMID: 29317883; PMCID: PMC5756308."},{"key":"13047_CR32","doi-asserted-by":"publisher","first-page":"107353","DOI":"10.1016\/j.actatropica.2024.107353","volume":"258","author":"Y Wang","year":"2024","unstructured":"Wang Y, Lai X, Liu R, Li J, Ren G, Lu X, Wu Y, Khan J, Yu X, Qiang Y, Lei S, Zhang Y, Lu G. Molecular prevalence and subtype characteristics of Blastocystis among school children in Hainan, the tropical island province of China. Acta Trop. 2024;258:107353. Epub 2024 Aug 8. PMID: 39122102.","journal-title":"Acta Trop"},{"key":"13047_CR33","doi-asserted-by":"publisher","unstructured":"Jones MS, Whipps CM, Ganac RD, Hudson NR, Boorom K. Association of Blastocystis subtype 3 and 1 with patients from an Oregon community presenting with chronic gastrointestinal illness. Parasitol Res. 2009;104(2):341\u20135. https:\/\/doi.org\/10.1007\/s00436-008-1198-7. Epub 2008 Oct 16. Erratum in: Parasitol Res. 2009;104(2):491. Boroom, Kenneth [corrected to Boorom, Kenneth]. PMID: 18923844.","DOI":"10.1007\/s00436-008-1198-7"},{"key":"13047_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1051\/parasite\/2024012","volume":"31","author":"W Zhao","year":"2024","unstructured":"Zhao W, Ren G, Wang L, Xie L, Wang J, Mao J, Sun Y, Lu G, Huang H. Molecular prevalence and subtype distribution of Blastocystis spp. among children who have diarrheia or are asymptomatic in Wenzhou, Zhejiang Province, China. Parasite. 2024;31:12. https:\/\/doi.org\/10.1051\/parasite\/2024012.","journal-title":"Parasite"},{"key":"13047_CR35","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez Ceruelos A, Romero-Quezada LC, Ruvalcaba Ledezma JC, L\u00f3pez Contreras L. Therapeutic uses of metronidazole and its side effects: an update. Eur Rev Med Pharmacol Sci. 2019;23(1):397\u2013401. https:\/\/doi.org\/10.26355\/eurrev_201901_16788 PMID: 30657582.","DOI":"10.26355\/eurrev_201901_16788"},{"issue":"2","key":"13047_CR36","doi-asserted-by":"publisher","first-page":"e0212542","DOI":"10.1371\/journal.pone.0212542","volume":"14","author":"A Rajamanikam","year":"2019","unstructured":"Rajamanikam A, Hooi HS, Kudva M, Samudi C, Kumar S. Resistance towards metronidazole in Blastocystis sp.: a pathogenic consequence. PLoS ONE. 2019;14(2):e0212542. https:\/\/doi.org\/10.1371\/journal.pone.0212542. PMID: 30794628; PMCID: PMC6386359.","journal-title":"PLoS ONE"},{"key":"13047_CR37","doi-asserted-by":"publisher","unstructured":"Roberts T, Bush S, Ellis J, Harkness J, Stark D. In vitro antimicrobial susceptibility patterns of blastocystis. Antimicrob Agents Chemother. 2015;59(8):4417-23. https:\/\/doi.org\/10.1128\/AAC.04832-14 Epub 2015 May 18. PMID: 25987633; PMCID: PMC4505275.","DOI":"10.1128\/AAC.04832-14"},{"key":"13047_CR38","doi-asserted-by":"publisher","first-page":"10386","DOI":"10.1016\/j.micpath.2019.103868","volume":"139","author":"M Aykur","year":"2020","unstructured":"Aykur M, Armagan G, Vardar R, Dagci H. Fecal calprotectin as a factor that supports the pathogenicity of Dientamoeba fragilis. Microb Pathogen. 2020;139:10386.","journal-title":"Microb Pathogen"},{"issue":"3","key":"13047_CR39","doi-asserted-by":"publisher","first-page":"e00007","DOI":"10.1128\/mSystems.00007-18","volume":"3","author":"ME Nieves-Ram\u00edrez","year":"2018","unstructured":"Nieves-Ram\u00edrez ME, Partida-Rodr\u00edguez O, Laforest-Lapointe I, Reynolds LA, Brown EM, Valdez-Salazar A, Mor\u00e1n-Silva P, Rojas-Vel\u00e1zquez L, Morien E, Parfrey LW, Jin M, Walter J, Torres J, Arrieta MC, Xim\u00e9nez-Garc\u00eda C, Finlay BB. Asymptomatic Intestinal Colonization with Protist Blastocystis Is Strongly Associated with Distinct Microbiome Ecological Patterns. mSystems. 2018;3(3):e00007\u201318. https:\/\/doi.org\/10.1128\/mSystems.00007-18. PMID: 29963639; PMCID: PMC6020473.","journal-title":"mSystems"},{"issue":"4","key":"13047_CR40","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s12639-021-01398-7","volume":"45","author":"HS Ibrahim","year":"2021","unstructured":"Ibrahim HS, Salem AI, Ahmed NMAE, El-Taweel HA. Pre-and post-treatment evaluation of intestinal inflammation in Giardia and Blastocystis infected children: a community-based study. J parasitic diseases: official organ Indian Soc Parasitol. 2021;45(4):1026\u201333. https:\/\/doi.org\/10.1007\/s12639-021-01398-7.","journal-title":"J parasitic diseases: official organ Indian Soc Parasitol"},{"issue":"1","key":"13047_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11686-022-00628-z","volume":"68","author":"EM Hussein","year":"2023","unstructured":"Hussein EM, Muhammad MAA, Hussein AM, Elzagawy SM, Zaki WM, Temsah AG, Badr MS, Alabbassy MM. Levels of Genetic Variants Among Symptomatic Blastocystis Subtypes and their Relationship to Mucosal Immune Surveillance in the Precancerous Colons of Experimentally Infected Rats. Acta Parasitol. 2023;68(1):70\u201383. https:\/\/doi.org\/10.1007\/s11686-022-00628-z. Epub 2022 Nov 15. PMID: 36380160; PMCID: PMC10011339.","journal-title":"Acta Parasitol"},{"issue":"4","key":"13047_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/pathogens14040313","volume":"14","author":"O Pawelec-P\u0119ciak","year":"2025","unstructured":"Pawelec-P\u0119ciak O, \u0141anocha-Arendarczyk N, Grzeszczak K, Kosik-Bogacka D. The Role of Blastocystis spp. in the Etiology of Gastrointestinal and Autoimmune Diseases. Pathogens. 2025;14(4):313. https:\/\/doi.org\/10.3390\/pathogens14040313.","journal-title":"Pathogens"},{"key":"13047_CR43","doi-asserted-by":"publisher","unstructured":"Azizian M, Basati G, Abangah G, Mahmoudi MR, Mirzaei A. Contribution of Blastocystis hominis subtypes and associated inflammatory factors in development of irritable bowel syndrome. Parasitol Res. 2016;115(5):2003-9. https:\/\/doi.org\/10.1007\/s00436-016-4942-4. Epub 2016 Feb 3. PMID: 26841770.","DOI":"10.1007\/s00436-016-4942-4"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13047-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13047-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:23:19Z","timestamp":1781644999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13047-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13047"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13047-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was conducted according to national and international guidelines for research ethics, and the ethical approval was obtained from the ethical committee of the Faculty of Medicine, Cairo University (N.99.2025). All procedures related to the human samples were in accordance Declaration of Helsinki 2000. Informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A consent for publication was obtained from each subject enrolled in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"744"}}